CAR-T Therapy: Safety, Efficacy, and Immune-Escape Mechanisms
The study is a biological, drug-related, non-treatment watch-and-measure (no experimental treatment required) study with both retrospective and prospective components. No experimental diagnostic procedures, investigational medicinal products, or medical devices will be used, and samples will be collected as part of routine clinical practice.
Official registry: https://clinicaltrials.gov/study/NCT07915102 · Ciceri Fabio · enrollment listed as 225
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 225 people at Milan. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Biological Observational Study for Monitoring Patients Receiving Chimeric Antigen Receptor T-cell (CAR-T) Therapies, Identifying Predictive Factors of Efficacy and Safety, and Understanding Immune-escape Mechanisms to Optimize Existing Platforms
Primary outcome (registry wording): Overall Response Rate (ORR)
Who it is for (from inclusion criteria)
- Ages 18 Years to any
- To achieve the objectives of this study, biological samples will be obtained from patients aged 18 years or older who meet at least one of the following who can join:
Who the registry excludes
- Participation in clinical trial protocols that explicitly prohibit participation in biological watch-and-measure (no experimental treatment required) studies
Contact
No central phone on the registry card. Use the official listing to reach a site.
Sites listed on ClinicalTrials.gov
1 listed- IRCCS San Raffaele Hospital — Milan, Italy, Italy (recruiting)
FAQ about this NCT record
Is NCT07915102 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT07915102?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT07915102?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary